Multi-omics analysis, evaluating genetic alteration and prognostic value of transcriptional dysregulation, shows GARS1 to have the highest association with cancer out of all the ARSs (Wang et al., 2020), especially for lung adenocarcinoma (Zhang et al., 2021). The gene discussed is GARS1; the disease is cancer.